Butyrate production pathway

The butyrate production pathway is a critical microbial metabolic process occurring in the human large intestine, where anaerobic bacteria ferment non-digestible carbohydrates into butyrate, a four-carbon short-chain fatty acid (Louis & Flint, 2009, FEMS Microbiol Lett). This pathway is a primary therapeutic target in microbiome research because butyrate serves as the essential energy source for colonocytes, providing approximately 70% of their total energy requirements and maintaining the intestinal barrier (Koh et al., 2016, Cell). Beyond its role as a fuel, butyrate acts as a potent signaling molecule by inhibiting histone deacetylases (HDACs) and activating specific G protein-coupled receptors, such as GPR41, GPR43, and GPR109A, which collectively regulate immune homeostasis and suppress pro-inflammatory cytokines (Parada Venegas et al., 2019, Front Immunol). Dysregulation or a decrease in the activity of this pathway is strongly associated with the pathogenesis of inflammatory bowel diseases, colorectal cancer, and metabolic disorders like type 2 diabetes (Riviere et al., 2016, Front Microbiol). Therapeutic interventions aim to enhance this pathway through the administration of prebiotics to stimulate endogenous butyrogenic bacteria, the use of probiotics containing species like Faecalibacterium prausnitzii, or the direct delivery of butyrate salts and prodrugs like tributyrin (Canani et al., 2011, World J Gastroenterol). Consequently, the butyrate production pathway represents a vital functional target for restoring gut health and managing systemic inflammatory conditions.

Other names

ButyrogenesisMicrobial butyrate synthesisShort-chain fatty acid production pathwayButyrate metabolic pathway

Enhancement of microbial fermentation through substrate provision or direct introduction of butyrogenic taxa to increase intraluminal butyrate, which inhibits histone deacetylases and activates G protein-coupled receptors (GPR41/43/109A).